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ABSTRACT 
Benign metastasising pleomorphic adenoma (BMPA) is an extremely rare tumour that is classified 
histologically. A 58-year-old-woman presented with Pleomorphic adenoma originated from parotid gland with 
lung metastasis without local recurrence: There is no effective treatment except total excision and closely 
monitoring a benign PA with metastasis is important. Herein we report a rare case because of the several cases 
with metastasis without local recurrences have been reported in the literature. 
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INTRODUCTION 
Pleomorphic adenoma (PA) is the most common salivary gland tumor; another name is 
"benign mixed tumor". The majorities (80%) are from the parotid gland [1]. Even though 
rarely presented with metastases without malignant transformation and local recurrence 
has been reported and histopathological type of this "benign metastasizing pleomorphic 
adenoma (BMPA) was given the name. In our study, we present a case of a BMPA without 
recurrence associated with bilateral multiple lung metastases. 
Case Report 
A Fifty-eight years old woman; a month ago, presented with swelling in the mouth from the 
otolaryngology clinic mass excision applied. Histopathology results reported as pleomorphic 
adenoma. Three months after the operation, on chest radiography; bilateral peripheral 
multiple metastatic lesions were established, the case referred to our clinic. Physical 
examination was normal. Thoracic computed tomography (CT) showed multiple metastatic 
nodules in both lungs [Figure 1]. Positron emission tomography (PET) in bilateral millimetric 
lung nodules observed fluorodeoxyglucose (FDG) uptake was not detected. Out of 
hypertension, restless leg syndrome, and chronic renal failure did not have a disease 
accompanying. The biochemical parameters were normal. Wedge resection was performed 
via video assisted thoracic surgery (VATS) a nodule in the middle lobe for diagnosis. This was 
due to the patient’s lack of respiration reserves; bilateral metastasectomy was not 
considered. The histopathological diagnosis was reported as BMPA [Figure 2A, B]. Surgical 
excision of the parotid mass was reported a dominant chondromyxoid stroma with the 
plasmacytoid morphology of the myoepithelial cells of a tumor. In the presence of tumor 
capsule invasion could not be assessed with certainly. In which both the lung metastasis and 
primary tumor had a same histologic apperance and Ki-67 proliferation index. In light of 
findings was not considered carcinoma ex-pleomorphic adenoma. The oncology council 
concluded to consult with the Medical Oncology and Radiation Oncology Clinic for external 
radiotherapy and chemotherapy. Three cycles of cisplatin75 mg/m
2
and doxorubicin 60 
mg/m
2
 chemotherapy and 30 Gray in 10 fraction radiotherapy were performed. Six-month 
after diagnosis, new metastasis were detected in celiac root, distal infrapancreatic area and 
mesenteric fat tissue. She is still alive two years after the initial diagnosis but, tumor 
metastases have dramatically increased. 
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DISCUSSION 
BMPA or "metastasizing mixed tumor" is called, is a very rare histopathologic type; although 
there is not a malignant character tends to metastasize to various organs [2]. In order for 
the PA to be diagnosed as being benign metastasizing pleomorphic adenoma (BMPA), two 
conditions must be met. First, the typical histological findings must not show the presence 
of malignant histological features such as anaplasia, necrosis, or atypical mitosis, such as 
invasive growth but, must show the same histological character with the primary tumor. 
Second, the metastases must share the same histological character as the primary tumor 
[2]. Although it is important to histologically monitor benign PA with metastasis, the 
condition can be explained using two theories. First, vascular or lymphatic invasion occurs in 
the primary tumor and second, in the metastases during the surgical procedure depending 
on whether the iatrogenic intravascular tumor implantation is a hematogenous spread 
metastasis. A hematogenous metastasis spread by regional lymphatic involvement is more 
common. On the other hand, metastatic lesions were reported in other systems [3]. 
Recurrence was detected in 90% of patients presenting with metastases in the primary 
tumor. Several cases with metastasis without local recurrence have been reported in the 
literature. The presence of a primary lesion 3-52 years after the initial diagnosis of 
metastases has been reported [4]. In our case, the metastasis was seen six months after the 
diagnosis, and local recurrence after surgical excision and surgical margin positivity were not 
detected. Metastasizing pleomorphic adenoma has a benign character although mortality 
rates can reach up to 22% [5]. In their study, Nouraei et al. [6] reported that the BMPA 5-
year disease free survival rate was 50%. It has been reported that 74% of BMPA cases occur 
in the parotid gland, 16% occur in the minor salivary glands, and 10% occur in the 
submandibular glands [6]. In our case, the BMPA originated in the parotid gland. When 
determining the aggressiveness of a malignant neoplasm, Ki-67 proliferation assay gene 
testing is extremely useful [7]. However, in their study of mostly low grade salivary gland 
tumors, Luuaakk et al. [7] found that Ki-67 antigen expression was negative. Flow cytometric 
analysis, oncogene analysis, and tumor suppressor gene analysis are insufficient for 
determining the metastatic potential of these tumors [8]. In our case, the Ki-67 proliferation 
index was positive in the glandular component, and the staining wasn’t observed in the 
mesenchymal components. Although there are no histological differences between BMPA 
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and PA, BMPA is an aggressive tumor. In the studies of L-myc, N-myc, C-myc, BMPA, Bcl2, C-
erbB2, Ha-ras, and Ki-ras oncogenes have also not been found by gene amplification or gene 
over expression. Immunohistochemical studies with tumor suppressor genes, like RB, and 
p16 and p53 tumor markers could detect deviations from normal tissue [8]. Nevertheless, it 
is not understood why BMPA is an aggressive tumor. Future studies on the biological causes 
of this condition are needed. Surgical excision is an adequate treatment, with a good 
prognosis. However, incomplete resection can lead to recurrence of the lesion. Complete 
resection via either a superficial or total parathyroidectomy is preferred to reduce the risk of 
local or metastatic recurrence [9]. Incomplete resection of metastases and local recurrence 
in patients with long-term follow-up is recommended. Chemotherapy and radiotherapy are 
not effective primary treatments. Recently, Knight and Ratnasingham [10] have published a 
systematic review of Metastasising Pleomorphic Adenoma. Eighty patients were included in 
this study, 26 (33.8%) of whom presented pulmonary metastases and may occur years after 
the initial PA and is associated with multiple local recurrences and, this is a negative 
prognostic factor [10]. Radiotherapy can be performed as an adjuvant, to better local 
control [10]. 
The case reported in the present paper showed the limited value of chemotherapy other 
than providing palliation in treating the metastasis and total surgical removal of lung 
metastases is important in appropriate cases. Future studies are needed to investigate 
diagnosis and tumor behavior, and to detect the biomarkers. 
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Figure 1  
Thoracic computed tomography shows bilateral multiple metastatic nodules in the lung 
parenchyma A: Coronal section B: Axial section 
 
Figure 2 
A: Arrow shows that Mixochondroid plasmacytoid appearance in stromal matrix with cords 
of cells forming benign epithelial-myoepithelial areas, occasionally forming small glandular 
structure of the ductal tumor control components are selected (H & E x 50).         B: Arrow 
shows that Pleural area with paved peribronchial nodular structure in the dominant 
component for myoepithelial tumor tissue (H&E x50). 
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